The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk NAFLD in primary care
Abstract 脂肪变性相关纤维化评估（SAFE）评分：一种在初级保健中检测低风险NAFLD的工具 Back…
Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis
Highlights Background & Aims Although the effect of…
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers
Abstract Background: Estimating the risk for …
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
Abstract Objective In retrospective studies, liver…
NAFLD-related hepatocellular carcinoma: The growing challenge
Abstract Hepatocellular carcinoma (HCC) is a …
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Summary Hepatocellular carcinoma (HCC) is a leading cau…